Zimbabwe has rejected a significant US healthcare agreement valued at $367m (£272m) over five years due to the United States' insistence on sensitive information.
This rejection became public following a government memo from December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the arrangement was "unbalanced".
An official representative later clarified that the United States was requesting genetic material for scientific study and profit but refused to guarantee the resulting advantages from any future medical innovations.
"We will now turn to the difficult and regrettable task of ending our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had donated over $1.9bn in health funding to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for more talks to reach a deal suitable to all parties so the country's vital HIV treatment initiative can proceed.
Broader Background
Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a court suspended a similar health funding agreement following concerns were raised about the safety of Kenyans' medical information.
Since returning to the presidency last year, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump stated its spending was "wasteful" and his government was seeking government-to-government agreements to enhance transparency and responsibility.
As per reports, Sixteen African countries have so far agreed to similar agreements, constituting over $18.3bn in new funding.
Details of the Rejected Deal
The funds for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this cooperation could have provided significant advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently on antiretroviral therapy through US-supported initiatives," Tremont commented.
However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".
"Our nation was requested to surrender its biological resources and data indefinitely, without any corresponding assurance of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," Mangwana explained.
"In essence, our country would supply the raw materials for medical research with no certainty that the resulting innovations would be accessible to our citizens should a new health crisis arise."
National Interest and International Frameworks
He also noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were disrupting frameworks already set up through the global organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to manage potential pandemics.
"This framework is intended to ensure that when a country contributes its information, the benefits – including vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We welcome ongoing discussions with our American counterparts on how subsequent collaboration might be structured in a manner that respects the sovereignty and dignity of both nations."
Health Experts Reaction
A leading public health body said it understood the official position, but suggested that negotiations must proceed considering a large portion of the nation's HIV programmes depended on external financing.
"If specific concerns exist, such as those involving data governance or agreement terms, these can often be resolved through detailed discussion and negotiated safeguards," it said.
This impasse underscores the ongoing tensions between accepting vital foreign assistance and protecting national sovereignty in an ever more data-driven world.